Skip to main content
Top
Published in: Inflammation 5/2014

01-10-2014

Protective Effects of Lactobacillus plantarum NDC 75017 Against Lipopolysaccharide-Induced Liver Injury in Mice

Authors: Xinyan Peng, Yujun Jiang

Published in: Inflammation | Issue 5/2014

Login to get access

Abstract

This study investigated the protective effect of Lactobacillus plantarum NDC 75017 (L. plantarum NDC 75017) against acute liver injury induced by lipopolysaccharide (LPS). Thirty male mice were randomly divided into the control, LPS, and LPS + L. plantarum NDC 75017 groups. In the LPS + L. plantarum group, the mice were orally pretreated with L. plantarum NDC 75017 for 15 days. At 16 days, the mice in the LPS and LPS + L. plantarum NDC 75017 groups were intraperitoneally injected with LPS at 4 mg/kg body weight, whereas the control mice were treated with an equal amount of saline. After 8 h, the serum alanine transaminase (ALT), aspartate aminotransferase (AST), and histology changes were examined. The oxidative stress markers and pro-inflammatory cytokines in the liver were also examined. Meanwhile, the expression of nuclear factor κB (NF-κB) mRNA and toll-like receptor 4 (TLR4) in the liver was determined by qRT-PCR. The LPS group showed an increase in ALT and AST, whereas the LPS + L. plantarum NDC 75017 group showed a significant decrease. In addition, pretreatment with L. plantarum NDC 75017 can attenuate LPS-induced oxidative stress and inflammatory response. Furthermore, the increase of hepatic NF-κB and TLR4 mRNA induced by LPS was significantly downregulated by the pretreatment with L. plantarum NDC 75017. These data show that pretreatment with L. plantarum NDC 75017 protects against LPS-induced oxidative stress and inflammatory injury in the liver of mice, which may be attributed to the inhibition of the TLR4-NF-κB pathway.
Literature
1.
go back to reference Laubach, H.J., P.M. Jakob, K.O. Loevblad, A.E. Baird, M.P. Bovo, R.R. Edelman, and S. Warach. 1998. A phantom for diffusion-weighted imaging of acute stroke. Journal of Magnetic Resonance Imaging 8: 1349–1354. Laubach, H.J., P.M. Jakob, K.O. Loevblad, A.E. Baird, M.P. Bovo, R.R. Edelman, and S. Warach. 1998. A phantom for diffusion-weighted imaging of acute stroke. Journal of Magnetic Resonance Imaging 8: 1349–1354.
2.
go back to reference Yang, R.B., M.R. Mark, A. Gray, A. Huang, M.H. Xie, M. Zhang, A. Goddard, W.I. Wood, A.L. Gurney, and P.J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395: 284–288.PubMedCrossRef Yang, R.B., M.R. Mark, A. Gray, A. Huang, M.H. Xie, M. Zhang, A. Goddard, W.I. Wood, A.L. Gurney, and P.J. Godowski. 1998. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395: 284–288.PubMedCrossRef
4.
go back to reference Winrow, V.R., P.G. Winyard, C.J. Morris, and D.R. Blake. 1993. Free radicals in inflammation: second messengers and mediators of tissue destruction. British Medical Bulletin 49: 506–522.PubMed Winrow, V.R., P.G. Winyard, C.J. Morris, and D.R. Blake. 1993. Free radicals in inflammation: second messengers and mediators of tissue destruction. British Medical Bulletin 49: 506–522.PubMed
5.
go back to reference Qureshi, S.T., P. Gros, and D. Malo. 1999. Host resistance to infection: genetic control of lipopolysaccharide responsiveness by TOLL-like receptor genes. Trends in Genetics 15: 291–294.PubMedCrossRef Qureshi, S.T., P. Gros, and D. Malo. 1999. Host resistance to infection: genetic control of lipopolysaccharide responsiveness by TOLL-like receptor genes. Trends in Genetics 15: 291–294.PubMedCrossRef
6.
go back to reference Shi, H., M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.S. Flier. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. Journal of Clinical Investigation 116: 3015–3025.PubMedCrossRefPubMedCentral Shi, H., M.V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J.S. Flier. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. Journal of Clinical Investigation 116: 3015–3025.PubMedCrossRefPubMedCentral
7.
go back to reference Jaeschke, H. 2011. Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. Journal of Gastroenterology and Hepatology 26(Suppl 1): 173–179.PubMedCrossRef Jaeschke, H. 2011. Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. Journal of Gastroenterology and Hepatology 26(Suppl 1): 173–179.PubMedCrossRef
9.
go back to reference Cross, M.L. 2002. Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunology and Medical Microbiology 34: 245–253.PubMedCrossRef Cross, M.L. 2002. Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. FEMS Immunology and Medical Microbiology 34: 245–253.PubMedCrossRef
10.
go back to reference Seimon, T.A., A. Obstfeld, K.J. Moore, D.T. Golenbock, and I. Tabas. 2006. Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages. Proceedings of the National Academy of Sciences of the United States of America 103: 19794–19799.PubMedCrossRefPubMedCentral Seimon, T.A., A. Obstfeld, K.J. Moore, D.T. Golenbock, and I. Tabas. 2006. Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages. Proceedings of the National Academy of Sciences of the United States of America 103: 19794–19799.PubMedCrossRefPubMedCentral
11.
go back to reference Ben Ari, Z., O. Avlas, O. Pappo, V. Zilbermints, Y. Cheporko, L. Bachmetov, R. Zemel, A. Shainberg, E. Sharon, F. Grief, and E. Hochhauser. 2012. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure. Cellular Physiology and Biochemistry 29: 41–50.PubMedCrossRef Ben Ari, Z., O. Avlas, O. Pappo, V. Zilbermints, Y. Cheporko, L. Bachmetov, R. Zemel, A. Shainberg, E. Sharon, F. Grief, and E. Hochhauser. 2012. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure. Cellular Physiology and Biochemistry 29: 41–50.PubMedCrossRef
12.
go back to reference Wang, Y., Y. Li, J. Xie, Y. Zhang, J. Wang, X. Sun, and H. Zhang. 2013. Protective effects of probiotic Lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and anti-inflammatory capacities. International Immunopharmacology 15: 30–37.PubMedCrossRef Wang, Y., Y. Li, J. Xie, Y. Zhang, J. Wang, X. Sun, and H. Zhang. 2013. Protective effects of probiotic Lactobacillus casei Zhang against endotoxin- and d-galactosamine-induced liver injury in rats via anti-oxidative and anti-inflammatory capacities. International Immunopharmacology 15: 30–37.PubMedCrossRef
13.
go back to reference Xu, R.Y., Y.P. Wan, Q.Y. Fang, W. Lu, and W. Cai. 2012. Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model. Journal of Clinical Biochemistry and Nutrition 50: 72–77.PubMedCrossRefPubMedCentral Xu, R.Y., Y.P. Wan, Q.Y. Fang, W. Lu, and W. Cai. 2012. Supplementation with probiotics modifies gut flora and attenuates liver fat accumulation in rat nonalcoholic fatty liver disease model. Journal of Clinical Biochemistry and Nutrition 50: 72–77.PubMedCrossRefPubMedCentral
14.
go back to reference Wang, Y., Y. Liu, A. Sidhu, Z. Ma, C. McClain, and W. Feng. 2012. Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. American Journal of Physiology - Gastrointestinal and Liver Physiology 303: G32–G41.PubMedCrossRefPubMedCentral Wang, Y., Y. Liu, A. Sidhu, Z. Ma, C. McClain, and W. Feng. 2012. Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. American Journal of Physiology - Gastrointestinal and Liver Physiology 303: G32–G41.PubMedCrossRefPubMedCentral
15.
go back to reference Ewaschuk, J., R. Endersby, D. Thiel, H. Diaz, J. Backer, M. Ma, T. Churchill, and K. Madsen. 2007. Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology 46: 841–850.PubMedCrossRef Ewaschuk, J., R. Endersby, D. Thiel, H. Diaz, J. Backer, M. Ma, T. Churchill, and K. Madsen. 2007. Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology 46: 841–850.PubMedCrossRef
16.
go back to reference Rishi, P., S.K. Mavi, S. Bharrhan, G. Shukla, and R. Tewari. 2009. Protective efficacy of probiotic alone or in conjunction with a prebiotic in Salmonella-induced liver damage. FEMS Microbiology Ecology 69: 222–230.PubMedCrossRef Rishi, P., S.K. Mavi, S. Bharrhan, G. Shukla, and R. Tewari. 2009. Protective efficacy of probiotic alone or in conjunction with a prebiotic in Salmonella-induced liver damage. FEMS Microbiology Ecology 69: 222–230.PubMedCrossRef
17.
go back to reference O'Sullivan, D.J. 2008. Genomics can advance the potential for probiotic cultures to improve liver and overall health. Current Pharmaceutical Design 14: 1376–1381.PubMedCrossRef O'Sullivan, D.J. 2008. Genomics can advance the potential for probiotic cultures to improve liver and overall health. Current Pharmaceutical Design 14: 1376–1381.PubMedCrossRef
18.
go back to reference Hathout, A.S., S.R. Mohamed, A.A. El-Nekeety, N.S. Hassan, S.E. Aly, and M.A. Abdel-Wahhab. 2011. Ability of Lactobacillus casei and Lactobacillus reuteri to protect against oxidative stress in rats fed aflatoxins-contaminated diet. Toxicon 58: 179–186.PubMedCrossRef Hathout, A.S., S.R. Mohamed, A.A. El-Nekeety, N.S. Hassan, S.E. Aly, and M.A. Abdel-Wahhab. 2011. Ability of Lactobacillus casei and Lactobacillus reuteri to protect against oxidative stress in rats fed aflatoxins-contaminated diet. Toxicon 58: 179–186.PubMedCrossRef
19.
go back to reference Liu, Y., C. Man, X. Lv, L. Han, Y. Xue, X. Yang, Y. Shan, Y. Zhang, and Y. Jiang. 2012. Lactobacillus plantarum NDC 75017 affects il-6 gene expression in Caco-2 cells. Wei Sheng Wu Xue Bao 52: 1237–1243.PubMed Liu, Y., C. Man, X. Lv, L. Han, Y. Xue, X. Yang, Y. Shan, Y. Zhang, and Y. Jiang. 2012. Lactobacillus plantarum NDC 75017 affects il-6 gene expression in Caco-2 cells. Wei Sheng Wu Xue Bao 52: 1237–1243.PubMed
20.
go back to reference Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25: 402–408.PubMedCrossRef Livak, K.J., and T.D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25: 402–408.PubMedCrossRef
21.
go back to reference Hochhauser, E., O. Avlas, R. Fallach, L. Bachmetov, R. Zemel, O. Pappo, A. Shainberg, and Z. Ben Ari. 2013. Bone marrow and nonbone marrow Toll like receptor 4 regulate acute hepatic injury induced by endotoxemia. PLoS One 8: e73041.PubMedCrossRefPubMedCentral Hochhauser, E., O. Avlas, R. Fallach, L. Bachmetov, R. Zemel, O. Pappo, A. Shainberg, and Z. Ben Ari. 2013. Bone marrow and nonbone marrow Toll like receptor 4 regulate acute hepatic injury induced by endotoxemia. PLoS One 8: e73041.PubMedCrossRefPubMedCentral
22.
go back to reference Rishi, P., S. Bharrhan, G. Singh, and I.P. Kaur. 2011. Effect of Lactobacillus plantarum and L-arginine against endotoxin-induced liver injury in a rat model. Life Sciences 89: 847–853.PubMedCrossRef Rishi, P., S. Bharrhan, G. Singh, and I.P. Kaur. 2011. Effect of Lactobacillus plantarum and L-arginine against endotoxin-induced liver injury in a rat model. Life Sciences 89: 847–853.PubMedCrossRef
23.
go back to reference Nardone, G., D. Compare, E. Liguori, V. Di Mauro, A. Rocco, M. Barone, A. Napoli, D. Lapi, M.R. Iovene, and A. Colantuoni. 2010. Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury. American Journal of Physiology - Gastrointestinal and Liver Physiology 299: G669–G676.PubMedCrossRef Nardone, G., D. Compare, E. Liguori, V. Di Mauro, A. Rocco, M. Barone, A. Napoli, D. Lapi, M.R. Iovene, and A. Colantuoni. 2010. Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury. American Journal of Physiology - Gastrointestinal and Liver Physiology 299: G669–G676.PubMedCrossRef
24.
go back to reference Kaur, G., N. Tirkey, S. Bharrhan, V. Chanana, P. Rishi, and K. Chopra. 2006. Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents. Clinical and Experimental Immunology 145: 313–321.PubMedCrossRefPubMedCentral Kaur, G., N. Tirkey, S. Bharrhan, V. Chanana, P. Rishi, and K. Chopra. 2006. Inhibition of oxidative stress and cytokine activity by curcumin in amelioration of endotoxin-induced experimental hepatoxicity in rodents. Clinical and Experimental Immunology 145: 313–321.PubMedCrossRefPubMedCentral
25.
go back to reference Moncada, S., R.M. Palmer, and E.A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 43: 109–142.PubMed Moncada, S., R.M. Palmer, and E.A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 43: 109–142.PubMed
26.
go back to reference Brashears, M.M., D. Jaroni, and J. Trimble. 2003. Isolation, selection, and characterization of lactic acid bacteria for a competitive exclusion product to reduce shedding of Escherichia coli O157:H7 in cattle. Journal of Food Protection 66: 355–363.PubMed Brashears, M.M., D. Jaroni, and J. Trimble. 2003. Isolation, selection, and characterization of lactic acid bacteria for a competitive exclusion product to reduce shedding of Escherichia coli O157:H7 in cattle. Journal of Food Protection 66: 355–363.PubMed
27.
go back to reference Hamilton-Miller, J.M. 2003. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. International Journal of Antimicrobial Agents 22: 360–366.PubMedCrossRef Hamilton-Miller, J.M. 2003. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. International Journal of Antimicrobial Agents 22: 360–366.PubMedCrossRef
28.
go back to reference Sartor, R.B. 2005. Probiotic therapy of intestinal inflammation and infections. Current Opinion in Gastroenterology 21: 44–50.PubMed Sartor, R.B. 2005. Probiotic therapy of intestinal inflammation and infections. Current Opinion in Gastroenterology 21: 44–50.PubMed
29.
go back to reference Deguchi, R., H. Nakaminami, E. Rimbara, N. Noguchi, M. Sasatsu, T. Suzuki, M. Matsushima, J. Koike, M. Igarashi, H. Ozawa, R. Fukuda, and A. Takagi. 2012. Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy. Journal of Gastroenterology and Hepatology 27: 888–892.PubMedCrossRefPubMedCentral Deguchi, R., H. Nakaminami, E. Rimbara, N. Noguchi, M. Sasatsu, T. Suzuki, M. Matsushima, J. Koike, M. Igarashi, H. Ozawa, R. Fukuda, and A. Takagi. 2012. Effect of pretreatment with Lactobacillus gasseri OLL2716 on first-line Helicobacter pylori eradication therapy. Journal of Gastroenterology and Hepatology 27: 888–892.PubMedCrossRefPubMedCentral
30.
go back to reference Giriwono, P.E., H. Shirakawa, H. Hokazono, T. Goto, and M. Komai. 2011. Fermented barley extract supplementation maintained antioxidative defense suppressing lipopolysaccharide-induced inflammatory liver injury in rats. Bioscience, Biotechnology, and Biochemistry 75: 1971–1976.PubMedCrossRef Giriwono, P.E., H. Shirakawa, H. Hokazono, T. Goto, and M. Komai. 2011. Fermented barley extract supplementation maintained antioxidative defense suppressing lipopolysaccharide-induced inflammatory liver injury in rats. Bioscience, Biotechnology, and Biochemistry 75: 1971–1976.PubMedCrossRef
31.
go back to reference Gad, M., P. Ravn, D.A. Soborg, K. Lund-Jensen, A.C. Ouwehand, and S.S. Jensen. 2011. Regulation of the IL-10/IL-12 axis in human dendritic cells with probiotic bacteria. FEMS Immunology and Medical Microbiology 63: 93–107.PubMedCrossRef Gad, M., P. Ravn, D.A. Soborg, K. Lund-Jensen, A.C. Ouwehand, and S.S. Jensen. 2011. Regulation of the IL-10/IL-12 axis in human dendritic cells with probiotic bacteria. FEMS Immunology and Medical Microbiology 63: 93–107.PubMedCrossRef
32.
go back to reference Mendis, E., M.M. Kim, N. Rajapakse, and S.K. Kim. 2008. Suppression of cytokine production in lipopolysaccharide-stimulated mouse macrophages by novel cationic glucosamine derivative involves down-regulation of NF-kappaB and MAPK expressions. Bioorganic and Medicinal Chemistry 16: 8390–8396.PubMedCrossRef Mendis, E., M.M. Kim, N. Rajapakse, and S.K. Kim. 2008. Suppression of cytokine production in lipopolysaccharide-stimulated mouse macrophages by novel cationic glucosamine derivative involves down-regulation of NF-kappaB and MAPK expressions. Bioorganic and Medicinal Chemistry 16: 8390–8396.PubMedCrossRef
33.
go back to reference Bengmark, S. 2006. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN Journal of Parenteral and Enteral Nutrition 30: 45–51.PubMedCrossRef Bengmark, S. 2006. Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN Journal of Parenteral and Enteral Nutrition 30: 45–51.PubMedCrossRef
34.
go back to reference McCabe, C., A. Samali, and T. O'Brien. 2006. Beta cell cytoprotective strategies: establishing the relative roles for iNOS and ROS. Biochemical and Biophysical Research Communications 342: 1240–1248.PubMedCrossRef McCabe, C., A. Samali, and T. O'Brien. 2006. Beta cell cytoprotective strategies: establishing the relative roles for iNOS and ROS. Biochemical and Biophysical Research Communications 342: 1240–1248.PubMedCrossRef
35.
go back to reference Herath, T.D., R.P. Darveau, C.J. Seneviratne, C.Y. Wang, Y. Wang, and L. Jin. 2013. Tetra- and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-kappaB signal transduction cascade and immuno-inflammatory response in human gingival fibroblasts. PLoS One 8: e58496.PubMedCrossRefPubMedCentral Herath, T.D., R.P. Darveau, C.J. Seneviratne, C.Y. Wang, Y. Wang, and L. Jin. 2013. Tetra- and penta-acylated lipid A structures of Porphyromonas gingivalis LPS differentially activate TLR4-mediated NF-kappaB signal transduction cascade and immuno-inflammatory response in human gingival fibroblasts. PLoS One 8: e58496.PubMedCrossRefPubMedCentral
36.
go back to reference Joo, H.M., Y.J. Hyun, K.S. Myoung, Y.T. Ahn, J.H. Lee, C.S. Huh, M.J. Han, and D.H. Kim. 2011. Lactobacillus johnsonii HY7042 ameliorates Gardnerella vaginalis-induced vaginosis by killing Gardnerella vaginalis and inhibiting NF-kappaB activation. International Immunopharmacology 11: 1758–1765.PubMedCrossRef Joo, H.M., Y.J. Hyun, K.S. Myoung, Y.T. Ahn, J.H. Lee, C.S. Huh, M.J. Han, and D.H. Kim. 2011. Lactobacillus johnsonii HY7042 ameliorates Gardnerella vaginalis-induced vaginosis by killing Gardnerella vaginalis and inhibiting NF-kappaB activation. International Immunopharmacology 11: 1758–1765.PubMedCrossRef
37.
go back to reference Shimazu, T., J. Villena, M. Tohno, H. Fujie, S. Hosoya, T. Shimosato, H. Aso, Y. Suda, Y. Kawai, T. Saito, S. Makino, S. Ikegami, H. Itoh, and H. Kitazawa. 2012. Immunobiotic Lactobacillus jensenii elicits anti-inflammatory activity in porcine intestinal epithelial cells by modulating negative regulators of the Toll-like receptor signaling pathway. Infection and Immunity 80: 276–288.PubMedCrossRefPubMedCentral Shimazu, T., J. Villena, M. Tohno, H. Fujie, S. Hosoya, T. Shimosato, H. Aso, Y. Suda, Y. Kawai, T. Saito, S. Makino, S. Ikegami, H. Itoh, and H. Kitazawa. 2012. Immunobiotic Lactobacillus jensenii elicits anti-inflammatory activity in porcine intestinal epithelial cells by modulating negative regulators of the Toll-like receptor signaling pathway. Infection and Immunity 80: 276–288.PubMedCrossRefPubMedCentral
38.
go back to reference Wang, H., and Y. Li. 2006. Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice. European Journal of Pharmacology 534: 194–201.PubMedCrossRef Wang, H., and Y. Li. 2006. Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice. European Journal of Pharmacology 534: 194–201.PubMedCrossRef
Metadata
Title
Protective Effects of Lactobacillus plantarum NDC 75017 Against Lipopolysaccharide-Induced Liver Injury in Mice
Authors
Xinyan Peng
Yujun Jiang
Publication date
01-10-2014
Publisher
Springer US
Published in
Inflammation / Issue 5/2014
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-9886-1

Other articles of this Issue 5/2014

Inflammation 5/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.